Literature DB >> 11450174

Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder.

Y Sun1, L Zhang, N L Johnston, E F Torrey, R H Yolken.   

Abstract

BACKGROUND: Bipolar disorder is a serious brain disease affecting more than a million individuals living in the USA. Epidemiological studies indicate a role for both genetic and environmental factors in the pathogenesis of this disorder. AIM: To identify RNA transcripts that are up- or down-regulated in the frontal cortex regions of individuals with bipolar disorder.
METHOD: Serial analysis of gene expression (SAGE) and reverse transcriptase-polymerase chain reaction were used to identify RNA transcripts which are differentially expressed in the frontal cortex of brains obtained postmortem from individuals with bipolar disorder compared with other psychiatric and control conditions.
RESULTS: Levels of RNA transcripts encoding the serotonin transporter protein and components of the NF-kappa B transcription factor complex are significantly increased in individuals with bipolar disorder compared with unaffected controls. Increased levels of expression of these RNA transcripts were also detected in the brains of some individuals with schizophrenia and unipolar depression.
CONCLUSION: The SAGE technique offers promise for the characterisation of complex human brain diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11450174     DOI: 10.1192/bjp.178.41.s137

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  15 in total

Review 1.  Impact of molecular medicine on neuropsychiatry: the clinician's perspective.

Authors:  J M Ryan; R Loy; P N Tariot
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

2.  Expression profiling to understand actions of NMDA/glutamate receptor antagonists in rat brain.

Authors:  Petri Törönen; Marcus Storvik; Anni-Maija Lindén; Outi Kontkane; Markéta Marvanová; Merja Lakso; Eero Castrén; Garry Wong
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  Quantitative assessment of transcriptome differences between brain territories.

Authors:  Michel de Chaldée; Marie-Claude Gaillard; Nicolas Bizat; Jean-Marie Buhler; Olivier Manzoni; Joël Bockaert; Philippe Hantraye; Emmanuel Brouillet; Jean-Marc Elalouf
Journal:  Genome Res       Date:  2003-07       Impact factor: 9.043

4.  Meta-analysis of 12 genomic studies in bipolar disorder.

Authors:  Michael Elashoff; Brandon W Higgs; Robert H Yolken; Michael B Knable; Serge Weis; Maree J Webster; Beata M Barci; E Fuller Torrey
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

Review 5.  Pathogenesis of depression: Insights from human and rodent studies.

Authors:  C Ménard; G E Hodes; S J Russo
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

6.  RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

Authors:  Jagadeesh Sridhara Rao; Matthew Kellom; Edmund Arthur Reese; Stanley Isaac Rapoport; Hyung-Wook Kim
Journal:  J Affect Disord       Date:  2011-09-16       Impact factor: 4.839

Review 7.  Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia.

Authors:  Meng Xia; Sofya Abazyan; Yan Jouroukhin; Mikhail Pletnikov
Journal:  Schizophr Res       Date:  2014-11-20       Impact factor: 4.939

8.  Gene expression profiling of rat cerebral cortex development using cDNA microarrays.

Authors:  Ki-Hwan Lee; Dong-Hyun Yu; Yong-Sung Lee
Journal:  Neurochem Res       Date:  2008-11-06       Impact factor: 3.996

9.  Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression.

Authors:  Leisa A Glantz; John H Gilmore; David H Overstreet; Kayvon Salimi; Jeffrey A Lieberman; L Fredrik Jarskog
Journal:  Schizophr Res       Date:  2010-01-13       Impact factor: 4.939

10.  A voxel-based diffusion tensor imaging study of white matter in bipolar disorder.

Authors:  Katie Mahon; Jinghui Wu; Anil K Malhotra; Katherine E Burdick; Pamela DeRosse; Babak A Ardekani; Philip R Szeszko
Journal:  Neuropsychopharmacology       Date:  2009-01-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.